At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
In Brief
A Phase 3 clinical trial evaluating Haloperidol, Chlorpromazine, and 2 other interventions for Delirium and 2 related conditions. Currently recruiting, targeting 42 participants across 1 site.
Detailed Summary
To examine the effects of haloperidol, chlorpromazine, valproic acid and placebo, in conjunction with standardized non-pharmacologic interventions, in the first line treatment of agitated delirium in hospitalized patients with cancer. This double-blind, randomized clinical trial aims to provide evidence on various therapeutic options for palliating delirium, thereby reducing delirium-related distress and ultimately alleviating suffering.
Study Details
Timeline
Interventions
Given by Vein (IV)
Given by Vein (IV)
Given by Vein (IV)
Given by Vein (IV)